MedPath

Gene Expression Outcomes in Interventions for Substance Using HIV+ Minority Men

Not Applicable
Completed
Conditions
Inflammation
Human Immunodeficiency Virus Infection
Interventions
Behavioral: Writing tasks
Behavioral: AWARENESS for Sexual Minorities
Registration Number
NCT03143205
Lead Sponsor
University of California, San Francisco
Brief Summary

This is a pilot study of a new 9-session individually delivered cognitive behavioral intervention targeting sexual minority stress. In this study, 40 HIV+ men sexual minority men will be recruited for the study then will be randomly assigned to either the new 9 session intervention or a writing task condition.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
40
Inclusion Criteria
  • Provide evidence or documentation of HIV positive status (e.g. a letter of diagnosis or medication bottles with matched photo ID)
  • Be English speaking
  • Be able to consent
  • Sexual activity with a man in the 3 years prior to initial contact or identification as gay or bisexual
  • Not currently be enrolled in formal substance abuse treatment
  • Report at least one occasion of drinking 5 or more drinks or of using an illicit substance in the previous 3 months, but not meet criteria for a severe substance use disorder.
Read More
Exclusion Criteria
  • Presence of a severe substance use disorder
  • Presence of current symptoms consistent with schizophrenia or bipolar disorder, which would indicate that an intervention targeting these symptoms would be more appropriate.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Writing tasksWriting tasksGroup receives writing-based sessions
AWARENESS for sexual minoritiesAWARENESS for Sexual MinoritiesGroup receives new CBT-based intervention
Primary Outcome Measures
NameTimeMethod
Change in Gene expressionBaseline, ~9 weeks (at conclusion of intervention), 4 month follow-up

Gene expression related to inflammation measured in blood

Secondary Outcome Measures
NameTimeMethod
Change in Substance UseBaseline, ~9 weeks (at conclusion of intervention), 4 month follow-up

Substance Use measured through Alcohol Smoking and Substance Involvement Screening Test (ASSIST)

Trial Locations

Locations (1)

University of California, San Francisco

🇺🇸

San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath